HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
Javené, October 9, 2023
HTL, pioneer in the development and production of innovative pharmaceutical-grade biopolymers, announces its new corporate social responsibility (CSR) strategy. It aims to accelerate the company’s commitment to its entire ecosystem and transform its activity into a positive and sustainable force.
The strategy includes 19 commitments, divided into three priority areas: responsibility to preserve the environment, exemplarity with employees, and citizenship with civil society.
We’re pleased to share our second CSR report, highlighting the actions and commitments we carried out throughout 2024.
A Global Scientific Gathering Dedicated to Hyaluronic Acid Innovation.
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.